The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Pathogenic Forms of Tau Inhibit Kinesin-Dependent Axonal Transport through a Mechanism Involving Activation of Axonal Phosphotransferases
Open accessAbstract
Aggregated filamentous forms of hyperphosphorylated tau (a microtubule-associated protein) represent pathological hallmarks of Alzheimer's disease (AD) and other tauopathies. While axonal transport dysfunction is thought to represent a primary pathogenic factor in AD and other neurodegenerative diseases, the direct molecular link between pathogenic forms of tau and deficits in axonal transport remain unclear. Recently, we demonstrated that filamentous, but not soluble, forms of wild-type tau inhibit anterograde, kinesin-based fast axonal transport (FAT) by activating axonal protein phosphatase 1 (PP1) and glycogen synthase kinase 3 (GSK3), independent of microtubule binding. Here, we demonstrate that amino acids 2-18 of tau, comprising a phosphatase-activating domain (PAD), are necessary and sufficient for activation of this pathway in axoplasms isolated from squid giant axons. Various pathogenic forms of tau displaying increased exposure of PAD inhibited anterograde FAT in squid axoplasm. Importantly, immunohistochemical studies using a novel PAD-specific monoclonal antibody in human postmortem tissue indicated that increased PAD exposure represents an early pathogenic event in AD that closely associates in time with AT8 immunoreactivity, an early marker of pathological tau. We propose a model of pathogenesis in which disease-associated changes in tau conformation lead to increased exposure of PAD, activation of PP1-GSK3, and inhibition of FAT. Results from these studies reveal a novel role for tau in modulating axonal phosphotransferases and provide a molecular basis for a toxic gain-of-function associated with pathogenic forms of tau.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · cited 1×
“7E), as well as the inferior and superior temporal gyri (data not shown) indicated that TNT1 reactivity followed the typical pattern of Braak staging (Braak and Braak, 1991).”
BackgroundNeurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease
Arriagada, P. V., Growdon, J. H., Hedley-Whyte, E. T., & Hyman, B. T. (1992) · Neurology · doi:10.1212/wnl.42.3.631 · Cited by 2,668
Microtubule-associated protein tau. A component of Alzheimer paired helical filaments.
Grundke-Iqbal, I., Iqbal, K., Quinlan, M., Tung, Y. C., Zaidi, M. S., & Wisniewski, H. M. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38495-8 · Cited by 1,778
Kosik, K. S., Joachim, C. L., & Selkoe, D. J. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.11.4044 · Cited by 1,459
Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer’s disease
Giannakopoulos, P., Herrmann, F. R., Bussière, T., Bouras, C., Kövari, E., Perl, D. P., Morrison, J. H., Gold, G., & Hof, P. R. (2003) · Neurology · doi:10.1212/01.wnl.0000063311.58879.01 · Cited by 1,118 · cited 2×
“…protein tau represent major pathological components in Alzheimer’s disease (AD) and other tauopathies (Grundke-Iqbal et al., 1986; Wood et al., 1986) and correlate with progressive cognitive decline in AD (Kosik et al., 1986; Arriagada et al., 1992; Giannakopoulos et al., 2003).”
BackgroundAlonso, A. D. C., Grundke-Iqbal, I., & Iqbal, K. (1996) · Nature Medicine · doi:10.1038/nm0796-783 · Cited by 859
Ebneth, A., Godemann, R., Stamer, K., Illenberger, S., Trinczek, B., Mandelkow, E.-M., & Mandelkow, E. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.143.3.777 · Cited by 820
Braak, F., Braak, H., & Mandelkow, E. M. (1994) · Acta Neuropathologica · doi:10.1007/bf00293315 · Cited by 772
Wood, J. G., Mirra, S. S., Pollock, N. J., & Binder, L. I. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.11.4040 · Cited by 749
Self-citationMonoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205
Goedert, M., Jakes, R., & Vanmechelen, E. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11484-e · Cited by 608
Schweers, O., Schönbrunn-Hanebeck, E., Marx, A., & Mandelkow, E. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)51080-8 · Cited by 567
Drubin, D. G., Feinstein, S. C., Shooter, E. M., & Kirschner, M. W. (1985) · The Journal of cell biology · doi:10.1083/jcb.101.5.1799 · Cited by 510
Tau Reduction Prevents Aβ-Induced Defects in Axonal Transport
Vossel, K. A., Zhang, K., Brodbeck, J., Daub, A. C., Sharma, P., Finkbeiner, S., Cui, B., & Mucke, L. (2010) · Science · doi:10.1126/science.1194653 · Cited by 486
Biernat, J., Mandelkow, E. M., Schröter, C., Lichtenberg‐Kraag, B., Steiner, B., Berling, B., Meyer, H., Mercken, M., Vandermeeren, A., & Goedert, M. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05204.x · Cited by 484
Axonal Transport Defects in Neurodegenerative Diseases
Morfini, G. A., Burns, M., Binder, L. I., Kanaan, N. M., LaPointe, N., Bosco, D. A., Brown, R. H., Brown, H., Tiwari, A., Hayward, L., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3463-09.2009 · Cited by 464
Self-citationMultiple-motor based transport and its regulation by Tau
Vershinin, M., Carter, B. C., Razafsky, D. S., King, S. J., & Gross, S. P. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607919104 · Cited by 457 · cited 1×
“Several studies on the role for tau in axonal transport dysfunction proposed a mechanism involving direct interference of tau with the binding of conventional kinesin to microtubules (Ebneth et al., 1998; Seitz et al., 2002; Vershinin et al., 2007).”
BackgroundQuantitative assessment of cortical synaptic density in Alzheimer's disease
Scheff, S. W., DeKosky, S. T., & Price, D. A. (1990) · Neurobiology of Aging · doi:10.1016/0197-4580(90)90059-9 · Cited by 446 · cited 1×
“In AD brains, dystrophic neurites, synaptic loss, and protein mislocalization (Scheff et al., 1990; Dessi et al., 1997) are all consistent with FAT deficits.”
BackgroundMutations causing neurodegenerative tauopathies
Goedert, M., & Jakes, R. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.08.007 · Cited by 438 · cited 2×
“The identification of tau mutations in hereditary tauopathies directly link tau to neurodegeneration (Goedert and Jakes, 2005).”
BackgroundGlobal Hairpin Folding of Tau in Solution
Jeganathan, S., von Bergen, M., Brutlach, H., Steinhoff, H.-J., & Mandelkow, E. (2006) · Biochemistry · doi:10.1021/bi0521543 · Cited by 432
Protein sequence and mass spectrometric analyses of tau in the Alzheimer's disease brain
Hasegawa, M., Morishima-Kawashima, M., Takio, K., Suzuki, M., Titani, K., & Ihara, Y. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)41890-x · Cited by 430
Phosphorylation of Tau by Fyn: Implications for Alzheimer's Disease
Lee, G., Thangavel, R., Sharma, V. M., Litersky, J. M., Bhaskar, K., Fang, S. M., Do, L. H., Andreadis, A., Van Hoesen, G., & Ksiezak-Reding, H. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.4162-03.2004 · Cited by 414
Self-citationThe Structural Basis of Monoclonal Antibody Alz50's Selectivity for Alzheimer's Disease Pathology
Carmel, G., Mager, E. M., Binder, L. I., & Kuret, J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.51.32789 · Cited by 402
Self-citationMorfini, G., Szebenyi, G., Elluru, R., Ratner, N., & Brady, S. T. (2002) · The EMBO Journal · doi:10.1093/emboj/21.3.281 · Cited by 401
Self-citationAxonal transport defects: a common theme in neurodegenerative diseases
Roy, S., Zhang, B., Lee, V. M.-Y., & Trojanowski, J. Q. (2005) · Acta Neuropathologica · doi:10.1007/s00401-004-0952-x · Cited by 372
Neurons May Live for Decades with Neurofibrillary Tangles
Morsch, R., Simon, W., & Coleman, P. D. (1999) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199902000-00008 · Cited by 370
Andreadis, A. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.08.010 · Cited by 311
Self-citationMicrotubule-Associated Protein Tau
Yen, S.-H., Nacharaju, P., Ko, L.-W., Kenessey, A., & Liu, W.-K. (1998) · Handbook of the Aging Brain · doi:10.1016/b978-012734610-6/50012-9 · Cited by 282
Jeganathan, S., Hascher, A., Chinnathambi, S., Biernat, J., Mandelkow, E.-M., & Mandelkow, E. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805300200 · Cited by 278
A novel CDK5‐dependent pathway for regulating GSK3 activity and kinesin‐driven motility in neurons
Morfini, G., Szebenyi, G., Brown, H., Pant, H. C., Pigino, G., DeBoer, S., Beffert, U., & Brady, S. T. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600237 · Cited by 268
Self-citationSingle-molecule investigation of the interference between kinesin, tau and MAP2c
Seitz, A., Kojima, H., Oiwa, K., Mandelkow, E.-M., Song, Y.-H., & Mandelkow, E. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf503 · Cited by 257 · cited 1×
“Several studies on the role for tau in axonal transport dysfunction proposed a mechanism involving direct interference of tau with the binding of conventional kinesin to microtubules (Ebneth et al., 1998; Seitz et al., 2002; Vershinin et al., 2007).”
BackgroundSelf-citationStructural Principles of Tau and the Paired Helical Filaments of Alzheimer's Disease
Mandelkow, E., Von Bergen, M., Biernat, J., & Mandelkow, E. (2007) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00053.x · Cited by 243 · cited 1×
“Tau was originally thought to exist in an extended random coil state based on spectroscopic studies (Mandelkow et al., 2007).”
BackgroundLaPointe, N. E., Morfini, G., Pigino, G., Gaisina, I. N., Kozikowski, A. P., Binder, L. I., & Brady, S. T. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.21850 · Cited by 240
Self-citationEarly N-Terminal Changes and Caspase-6 Cleavage of Tau in Alzheimer's Disease
Horowitz, P. M., Patterson, K. R., Guillozet-Bongaarts, A. L., Reynolds, M. R., Carroll, C. A., Weintraub, S. T., Bennett, D. A., Cryns, V. L., Berry, R. W., & Binder, L. I. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1988-04.2004 · Cited by 215
Self-citationBarghorn, S., Davies, P., & Mandelkow, E. (2004) · Biochemistry · doi:10.1021/bi0357006 · Cited by 209
Axonal Transport Rates In Vivo Are Unaffected by Tau Deletion or Overexpression in Mice
Yuan, A., Kumar, A., Peterhoff, C., Duff, K., & Nixon, R. A. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.5242-07.2008 · Cited by 190
Protein Phosphatase 1 Is Targeted to Microtubules by the Microtubule-associated Protein Tau
Liao, H., Li, Y., Brautigan, D. L., & Gundersen, G. G. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.34.21901 · Cited by 172
Functions and malfunctions of the tau proteins
Shahani, N., & Brandt, R. (2002) · Cellular and Molecular Life Sciences · doi:10.1007/pl00012495 · Cited by 171
Ligand-Dependent Tau Filament Formation: Implications for Alzheimer's Disease Progression
King, M. E., Ahuja, V., Binder, L. I., & Kuret, J. (1999) · Biochemistry · doi:10.1021/bi9911839 · Cited by 170
Self-citationGlycogen Synthase Kinase-3β Is Complexed with Tau Protein in Brain Microtubules
Sun, W., Qureshi, H. Y., Cafferty, P. W., Sobue, K., Agarwal-Mawal, A., Neufield, K. D., & Paudel, H. K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107182200 · Cited by 124
Fast Axonal Transport Misregulation and Alzheimer's Disease
Morfini, G. A., Pigino, G. F., Beffert, U., Busciglio, J. A., & Brady, S. T. (2002) · NeuroMolecular Medicine · doi:10.1385/nmm:2:2:089 · Cited by 104
Self-citationKosik, K. S., Joachim, C., & Selkoe, D. J. (1987) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-198701030-00022 · Cited by 100
Tau binding to microtubules does not directly affect microtubule‐based vesicle motility
Morfini, G. A., Pigino, G. F., Mizuno, N., Kikkawa, M., & Brady, S. T. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21154 · Cited by 91
Self-citationKozikowski, A. P., Gaisina, I. N., Yuan, H., Petukhov, P. A., Blond, S. Y., Fedolak, A., Caldarone, B. J., & McGonigle, P. (2007) · Journal of the American Chemical Society · doi:10.1021/ja068969w · Cited by 91
A possible link between astrocyte activation and tau nitration in Alzheimer's disease
Reyes, J. F., Reynolds, M. R., Horowitz, P. M., Fu, Y., Guillozet-Bongaarts, A. L., Berry, R., & Binder, L. I. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.04.005 · Cited by 88
Self-citationKanaan, N. M., Kordower, J. H., & Collier, T. J. (2007) · The Journal of Comparative Neurology · doi:10.1002/cne.21333 · Cited by 83
Self-citationDegradation of Tau Protein by Puromycin-Sensitive Aminopeptidase in Vitro
Sengupta, S., Horowitz, P. M., Karsten, S. L., Jackson, G. R., Geschwind, D. H., Fu, Y., Berry, R. W., & Binder, L. I. (2006) · Biochemistry · doi:10.1021/bi061830d · Cited by 78
Self-citationNovel isoforms of tau that lack the microtubule‐binding domain
Luo, M., Tse, S., Memmott, J. E., & Andreadis, A. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02508.x · Cited by 58
Self-citationTakahashi, M., Weidenheim, K. M., Dickson, D. W., & Ksiezak-Reding, H. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.1.33 · Cited by 56
Partial deletion of theMAPTgene: A novel mechanism of FTDP-17
Rovelet‐Lecrux, A., Lecourtois, M., Thomas-Antérion, C., Ber, I. L., Brice, A., Frébourg, T., Hannequin, D., & Campion, D. (2009) · Human Mutation · doi:10.1002/humu.20979 · Cited by 48
Tau epitope display in progressive supranuclear palsy and corticobasal degeneration
Berry, R. W., Sweet, A. P., Clark, F., Lagalwar, S., Lapin, B. R., Wang, T., Topgi, S., Guillozet-Bongaarts, A. L., Cochran, E., Bigio, E. H., et al. (2004) · Journal of Neurocytology · doi:10.1023/b:neur.0000044190.96426.b9 · Cited by 44
Self-citationShiarli, A.-M., Jennings, R. E., Shi, J., Bailey, K. L., Davidson, Y. S., Tian, J., Bigio, E. H., Ghetti, B. F., Murrell, J. R., Delisle, M., et al. (2006) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2006.00736.x · Cited by 43
Accumulation of SNAP-25 immunoreactive material in axons of Alzheimerʼs disease
Dessi, F., Colle, M.-A., Hauw, J., & Duyckaerts, C. J. (1997) · Neuroreport · doi:10.1097/00001756-199712010-00006 · Cited by 39
Chapter 14 Assay of Vesicle Motility in Squid Axoplasm
Brady, S. T., Richards, B. W., & Leopold, P. L. (1993) · Methods in cell biology · doi:10.1016/s0091-679x(08)60171-5 · Cited by 34
Self-citationSakai, K., Piao, Y.-S., Kikugawa, K., Ohara, S., Hasegawa, M., Takano, H., Fukase, M., Nishizawa, M., Kakita, A., & Takahashi, H. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0093-5 · Cited by 27
Higuchi, M., Saido, T. C., & Suhara, T. (2006) · Neuropathology · doi:10.1111/j.1440-1789.2006.00685.x · Cited by 5
Cited by
Tau in physiology and pathology
Wang, Y., & Mandelkow, E. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2015.1 · Cited by 2,251
The Intersection of Amyloid Beta and Tau at Synapses in Alzheimer’s Disease
Spires-Jones, T. L., & Hyman, B. T. (2014) · Neuron · doi:10.1016/j.neuron.2014.05.004 · Cited by 1,201
Tau pathology and neurodegeneration
Spillantini, M. G., & Goedert, M. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70090-5 · Cited by 1,133
Roles of tau protein in health and disease
Guo, T., Noble, W., & Hanger, D. P. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1707-9 · Cited by 1,003
Biochemistry and Cell Biology of Tau Protein in Neurofibrillary Degeneration
Mandelkow, E.-M., & Mandelkow, E. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006247 · Cited by 847
Metadata
- Authors
- Kanaan, N. M., Morfini, G. A., LaPointe, N. E., Pigino, G. F., Patterson, K. R., Song, Y., Andreadis, A., Fu, Y., Brady, S. T., & Binder, L. I.
- Venue
- Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2011-07-06
- Volume
- 31
- Issue
- 27
- Pages
- 9858-9868
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W2158314129
- Cited by
- 272
- References
- 55
- FWCI
- 10.40
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.